Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Daniel LaBarbera

Concepts (292)

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with Daniel LaBarbera's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Daniel LaBarbera has written about over time.
Acridines, 3 publications between 2007 and 2014, average publication date June 2011. Antineoplastic Agents, 11 publications between 2005 and 2022, average publication date December 2012. Topoisomerase II Inhibitors, 3 publications between 2005 and 2019, average publication date March 2013. Drug Screening Assays, Antitumor, 8 publications between 2007 and 2020, average publication date June 2013. Hydrolyzable Tannins, 4 publications between 2012 and 2014, average publication date June 2013. DNA Topoisomerases, Type II, 5 publications between 2007 and 2019, average publication date January 2014. Antigens, Neoplasm, 3 publications between 2011 and 2016, average publication date April 2014. Aldehyde Reductase, 7 publications between 2012 and 2018, average publication date September 2014. Plant Extracts, 2 publications between 2012 and 2017, average publication date December 2014. Spheroids, Cellular, 4 publications between 2011 and 2020, average publication date December 2014. Cell Line, Tumor, 19 publications between 2006 and 2022, average publication date March 2016. Enzyme Inhibitors, 5 publications between 2013 and 2020, average publication date April 2016. Drug Discovery, 7 publications between 2012 and 2022, average publication date May 2017. Epithelial-Mesenchymal Transition, 5 publications between 2011 and 2021, average publication date October 2017. DNA-Binding Proteins, 6 publications between 2011 and 2023, average publication date March 2018. Colorectal Neoplasms, 2 publications between 2019 and 2020, average publication date February 2020. TCF Transcription Factors, 2 publications between 2019 and 2020, average publication date February 2020. Neoplasms, 5 publications between 2012 and 2023, average publication date May 2020. DNA Helicases, 3 publications between 2020 and 2023, average publication date March 2022. Urinary Bladder Neoplasms, 3 publications between 2021 and 2022, average publication date May 2022.

To see the data from this visualization as text, click here.
LaBarbera's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)